Trending News 204d78

Pdd Stock PDD Stock Price Drops After Revenue Misses Expectations Key Takeaways PDD stock price dropped 14% on Friday after the company reported weaker-than-expected revenue in its latest earnings report. The company's revenue came in at $3.4 billion, below the consensus estimate of $3.5 billion. PDD attributed the revenue miss to slower-than-expected growth in its core e-commerce business. PDD Stock Price Drops PDD stock price fell sharply on Friday after the company reported weaker-than-expected revenue in its latest earnings report. The company's revenue came in at $3.4 billion, below the consensus estimate of $3.5 billion. PDD attributed the revenue miss to slower-than-expected growth in its core e-commerce business. Revenue Miss PDD's revenue growth has slowed in recent quarters as the company faces increased competition from rivals such as Alibaba and JD.com. In the latest quarter, PDD's revenue growth decelerated...

What's Next for Ben Chilwell After Ending the Transfer Window Still at Chelsea The Left-Back's Future at Stamford Bridge Will He Stay or Go? Ben Chilwell has been a valuable member of Chelsea's squad since joining from Leicester City in 2020. The left-back has made 73 appearances for the club, scoring four goals and providing 10 assists. However, Chilwell has been linked with a move away from Chelsea in recent months, with Arsenal and Newcastle United both reportedly interested in signing him. The 26-year-old's contract at Stamford Bridge expires in 2025, but it is thought that he could be sold this summer if Chelsea receives a suitable offer. Chilwell's Impact at Chelsea Chilwell has been a reliable performer for Chelsea, providing both defensive stability and attacking threat down the left flank. He has been praised for his ability to get forward and create chances, as well as his strong tackling and positioning. Chilwell played a key role in Che...

Bayer AG Wins US Court Ruling on Cancer Lawsuit Landmark Decision Could Impact Future Cases Bayer AG (OTCMKTS: BAYRY) saw its shares soar by up to 12% on Friday following a favorable court ruling in the US. The decision, made by a Philadelphia appeals court, could have significant implications for Bayer and other companies facing similar litigation. The lawsuit in question alleges that Bayer's Roundup weedkiller contains glyphosate, a chemical linked to cancer. Bayer has maintained that Roundup is safe and has vigorously defended itself against the claims. The appeals court's ruling overturned a lower court decision that had allowed the case to proceed. The court found that the plaintiffs had failed to provide sufficient evidence to support their claims. This ruling is a major victory for Bayer and could set the stage for future dismissals of similar lawsuits. Key Points: * Bayer AG won a significant legal victory in a long-running cancer litigation case. * The rul...